Quantification of 68 Ga-FAPI-04 in systemic sclerosis-associated interstitial lung disease.

Competing Interests: BB and BGJCZ declare no competing interests. CJvdL reports grants and personal fees from Pfizer, Abbvie, Bristol Myers Squibb, UCB, Galapagos, and GlaxoSmithKline, outside the submitted work. AEV reports grants and personal fees from Boehringer Ingelheim, personal fees from GlaxoSmithKline, and grants from UCB, outside the submitted work.